Loading

Journal of Urology and Research

Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature

Short Communication | Open Access

  • 1. Department of Urology, Medical College of Georgia at Augusta University, USA
  • 2. Department of Urology, University of Toronto, Canada
  • 3. Department of Urology, University of Michigan, USA
+ Show More - Show Less
Corresponding Authors
William G. Simpson, Department of Urology, Medical College of Georgia at Augusta University, 1120 15th street, Suite BAA-8415, Augusta, GA 30912-4050, USA, Tel: 170-67212519
Absract

Introduction: The treatment for penile cancer has been shown to cause harmful psychiatric symptoms as well as have detrimental effects on well-being. In the past several years, alternatives to total or partial penectomy have emerged, such as chemotherapy, radiation, penile sparing, and laser ablation therapies. Since we have published on this topic in general, a more specific breakdown for penile cancer is in order as the therapy has the potential for life changing surgery.

Materials and methods: We examined the SEER (1973-2013) database, comprising of 28% of the U.S. population. ICD-10 codes C60.8-C60.9 and the ICD-O codes 8010/2, 8010/3, 8051/2, 8051/3, 8052/2, 8052/3, 8070/2, 8070/3- 8072/3, 8074/3, 8076/3, and 8083/3-8084/3 were used. Age, race, marital status, and psychological variables were studied. We used contingency tables of suicide rates; mid-P exact test was used for analysis.

Results: There were 13 suicides were noted in 6,155 patients with squamous cell carcinoma of the penis. All patients that committed suicide had undergone a surgical intervention.

Conclusion: There is no doubt that penile cancer after treatment has a powerful effect on quality of life as increased depression and sexual anxiety have been continuously documented in post-op patients. This is in stark contrast to the observed suicide rate. Despite the reported negative psychologic effects in patients with penile cancer, suicide rates are amongst the lowest of all urologic malignancies.

Citation

Simpson WG, Klaassen Z, Jen RP, Neal DE, Terris MK (2017) Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature. J Urol Res 4(1): 1077

ABBREVIATIONS

HRQOL: Health Related Quality of Life, OR: Odds Ratio, SCC: Squamous Cell Carcinoma

INTRODUCTION

Penile cancer is one of the more uncommon urologic cancers. The incidence in Europe and the US is close to 1 in 100,000 men [1,2], while it represents 10-20% of malignancy in men in Africa, Asian, and South America [3]. Squamous cell carcinoma (SCC) makes up> 95% of penile cancers with the most common risk factors being HPV-16, HPV-18, phimosis, smoking, and lower socio-economic status [2,4]. The average age of diagnosis is 60 years and the malignancy is more likely to be seen in men that are not married (OR 2.5) [1,5]. The impact of penile cancer has been shown to cause significant psychological/psychiatric impact.

The treatment for penile cancer varies significantly depending on cancer stage and has been shown to cause harmful psychiatric symptoms in approximately 50% of patients as well as have detrimental effects on well-being in up to 40% of patients [2]. More aggressive treatments such as a partial penectomy have been shown to cause anxiety in 31-58% of patients and depression in 39% of patients [6,7] with significantly higher rates of anxiety in patients treated with a total penectomy [8]. Much of these psychological/psychiatric effects are thought to be secondary to the devastating effect on a man’s self-image and sexual function [7,9]. For that reason, modalities such as penile sparing surgical approaches, chemotherapy/radiation protocols, and laser ablative surgeries have been investigated as options to sexuality and HRQOL [9-11].

Approximately 70% of suicides in the elderly (> 60 years-old) are attributed to physical illness and malignancy [12]. We sought to investigate the risk of suicide in patients with penile cancer.

MATERIALS AND METHODS

Data sources

Patients with penile cancer were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The SEER database reports cancer-specific outcomes from specific geographic areas representing 28% of the US population [13]. The study cohort consisted of patients from all 18 registries comprising SEER from 1973 through 2013. Comparisons with the general US population were based on data from the Centers for Disease Control and Prevention’s National Center for Injury Prevention and Control (1999-2010) [14].

Study population

Patients were identified in the SEER database using the primary site code C60.8-C60.9 for penile cancer. To increase generalizability, squamous cell carcinoma histology for penile cancer was identified using International Classification of Diseases for Oncology (ICD-O) codes, specifically ICD-O codes 8010/2, 8010/3, 8051/2, 8051/3, 8052/2, 8052/3, 8070/2, 8070/3-8072/3, 8074/3, 8076/3, and 8083/3-8084/3.

Description of variables

Demographic variables of interest included age at the time of diagnosis (by decade), race (African American vs white vs other), and marital status (married vs single/divorced/widowed [SDW]). Clinical and pathologic variables included disease SEER histologic grade, and SEER stage (localized vs regional vs distant vs unstaged). Previous studies have determined important psychosocial/environmental risk factors for suicide, including but not limited to heavy alcohol and drug use, perceived sadness/hopelessness, low academic achievement, poor perceived health status, and high perceived stress [15]. Given the variables available in the SEER database, only the aforementioned demographic, clinical, and pathologic variables were used for the current analysis. The primary outcome was suicide (yes/no). Patients were considered to have committed suicide as previously described [16]. Overall survival was calculated for those dead of suicide (DOS) and those dead of causes other than suicide (DOC). Contingency tables of suicide rates were calculated as previously described [3]. Standardized mortality ratios (SMRs) and 95% confidence intervals (95% CIs) were calculated using the mid-P exact test as previously described [17]. Briefly, suicide rates (number of suicides divided by person-years of survival) were calculated to allow comparison between the anatomic cancer site and the general population [14,16]. Calculated SMRs for the US population based on age ranges 58-77 years) [14].

 

RESULTS

There were suicides identified among 1,239,522 individuals with genitourinary malignancies observed for 7,307,377 personyears. There were 13 suicides out of 6,155 patients with penile cancer (SMR, 1.58; 95% CI, 1.18-2.11) (Table 1). Of the 6,155 patients with penile cancer, 5,569 underwent surgical treatment for their disease. 593 patients chose to undergo adjuvant or solitary radiation therapy. All 13 suicides recorded were amongst those who had undergone a surgical intervention (partial penectomy, total penectomy, etc) and 1 who had undergone adjuvant radiation. The median overall survival for penile cancer for DOS was 37 months and for DOC was 25 months. All patients who committed suicide were between the ages of 50-79 years of age. 11 patients were married while 2 were SDW. 

As with other malignancies, there was an increased risk of suicide in white patients and with advancing age with penile cancer (Table 1). Unlike other malignancies in which suicide risk is greater in advanced stage and grade and in single/divorced/ widowed patients, penile cancer demonstrated an inverse association with cancer stage/grade (Table 2) and marital status (Table 1).

Table 1: Incidence of Suicide Among Patients with Penile Cancer by Demographic Characteristics (1973-2013).

Factor Persons Number of 
Suicides
Person-Years Suicide Rates per 
100,000 PersonYears
SMR 95% CI
Population 6,155 13 34,197 38 1.58 1.18-2.11
≤ 39 248 0 2,067 0 - -
40-49 558 0 4,745 0 - -
50-59 1,020 5 7,409 67 2.56 2.04-3.19
60-69 1,575 5 9,138 55 2.43 1.88-3.08
70-79 1,602 3 7,620 39 1.39 1.04-1.84
≥ 80 1,152 0 3,218 0 - -
Marital Status            
Married 3,556 11 22,269 49 2.05 1.57-2.64
SDW 2,154 2 9,712 21 0.84 0.56-1.21
Unknown 445 0 2,216 0 - -
Race            
African American 607 0 3,114 0 - -
Caucasian 5,221 13 29,270 44 1.67 1.26-2.17
Other 270 0 1,490 0 - -
Unknown 57 0 322 0 - -
Abbreviations: 95% CI, 95% confidence interval; SDW, single/divorced/widowed; SMR, standardized mortality ratio.
a Compared with suicide rates of the general US population according to the Centers for Disease Control and Prevention’s Web-based Injury Statistics Query and Reporting System (WISQARS) (1999-2010).

 

DISCUSSION AND CONCLUSION

Although more prevalent in underdeveloped countries, penile cancer is a rare urologic disease in the US and European countries. Analysis of the SEER database from 1998-2003 found 4967 cases of penile cancer with an incidence of 0.81 per 100,000 white males and 0.82 per 100,000 African American males.11Surgical treatment of penile cancer causes harmful psychiatric symptoms in approximately 50% of patients as well as have detrimental effects on well-being in up to 40% of patients.2 Varying treatment modalities affected sexual health, assessed most commonly by the IIEF-15, differently and are associated with different degrees of psychological impact (Table 3).

Both penile sparing and laser ablative therapies with the YAG laser are associated with fewer psychiatric effects. This is likely due to the fact that patients undergoing penile sparing surgery recover similar sexual function (as high as 72%) and have a satisfactory HRQOL [10,11]. Kieffer et al., found that patients who underwent penile sparing (n=54) there were few differences in HRQOL compared to the normative population and they also suffered from less problems with life interference and body image when compare to patient who underwent a partial penectomy [9]. Therapies such as the YAG laser (combined carbon dioxide and neodymium) can be considered in patient with Tis-T2, GI-II tumors less than 3cm (95% cancer specific survival at 5 yrs) with low recurrence rates (19%) [14].

Partial penectomy, commonly reserved for tumors confined to the glands or distal shaft, has been shown in the literature to have mixed psychiatric/psychologic effects. Many articles, using the IIEF-15, have reported significant impairment in erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall sexual satisfaction, and body image [6-8,18]. Yu et al., conducted a prospective study of 43 men with penile cancer undergoing partial penectomy in 2015; they assessed preand post-operative sexual health using the IIEF-15 and found there to be a significant difference in each domain of the survey. Furthermore, patients undergoing partial penectomy were found to higher levels of anxiety and depression (as high as 58% and 39% respectively) [6,8,18]. Individuals with proximally invasive penile cancer requiring a total penectomy have significantly higher anxiety levels compared to those undergoing a partial penectomy [8].

Malignancy has been shown to be a significant cause of suicide in those greater than 60 years old. Our prior analysis of the SEER database from 1973-2013, we found 2276 suicides in patients with urologic cancer (Prostate cancer: 1613, Bladder cancer: 439, Kidney cancer: 140, Testis cancer: 71, Penile cancer: 13). Despite all the detrimental psychological effects that treatments for penile cancer have, only 13 of the 2276 patients that committed suicide had penile cancer. The current analysis shows that those patients committing suicide with penile cancer also do not follow trends observed for other malignancies, particularly the fact that penile cancer patients with low grade and stage were more likely to commit suicide. This fact contradicts many of the studies in the literature reporting improved HRQOL with lower grade and stage tumors treated conservatively (Table 3).

Although the literature reports mixed effects on men’s HRQOL and sexual health, the overwhelming majority of articles analyzing those who underwent partial or total penectomy reported significant increases in anxiety and depression and significant decreases in sexual health. This topic has been investigated more thoroughly in penile cancer than any other urologic cancer. In our retrospective analysis, all 13 patients had undergone some form of surgical intervention of unknown approach. However,

despite all the detrimental effects reported, penile cancer has not been shown to cause increased risk for suicide compared to other urologic malignancies. One explanation for this may be the fact that penile cancer is so rare and therefore more retrospective studies of large databases should be carried out.

Table 2: Incidence of Suicide Among Patients With Penile Cancer by Clinicopathologic Characteristics

Factor Persons Number of 
Suicides
Person-Years Suicide Rates per 
100,000 PersonYears
SMR 95% CI
                                                          Grade
Well differentiated; 
Grade I
1,609 4 10,708 37 1.55 1.15-        2.07
Moderately 
differentiated; Grade II
2,163 3 10,438 29 1.17 0.82-1.60
Poorly differentiated; 
Grade III
1,011 2 4,002 50 2.01 1.53-2.56
Undifferentiated; 
Anaplastic; Grade IV
43 0 209 0 - -
Unknown 1,329 4 8,840 45 1.84 1.41-2.41
Stage            
Localized 3,774 10 24,186 41 1.71 1.29-2.26
Regional 1,771 3 3,494 86 3.42 2.78-4.14
Distant 295 0 452 0 - -
Unstaged 315 0 1,566 0 - -
                                                  Surgery Performed
Yes 5,569 13 32,167 40 1.62 1.22-2.14
No 535 0 1,789 0 - -
Unknown 51 0 241 0 - -
                                                 Radiation Performed
Yes 593 1 2,76 36 1.5 1.11-2.02
No 5,481 12 31,121 39 1.57 1.16-2.08
Unknown 81 0 314 0 - -
Abbreviations: 95% CI, 95% confidence interval; RPLND, retroperitoneal lymph node dissection; SMR, standardized mortality ratio.
a Compared with suicide rates of the general US population according to the Centers for Disease Control and Prevention’s Web-based Injury Statistics Query and Reporting System (WISQARS) (1999-2010).

 Table 3: Studies reviewed for psychological/psychiatric effects of penile cancer.

Author Sample 
Size
Mean Age Design Intervention Parametric Tool Findings
Yu et al ., 20166 43 56 Prospective Partial Pen (n= 43) IIEF-15
SAS
SDS
Pre and Postop IIEF-15 scores were 
significantly different in each domain. 
Postop Anxiety and depression seen in 
58% and 39% respectively
Kieffer et al ., 20149 90 65.4 Retrospective Penile sparing (n=54) Partial Pen (n=36) SF-36 
IIEF-15
IOC (version 2)
Few differences were observed in sexuality or health related QOL compared to normative population. Partial Pen associated with more problems with life interference and body image
Novac et al ., 20138 11 62.9 Retrospective Total Pen (n=2) 
Partial Pen (n=6) 
Biopsy (n=3)
HAM-A 
 HAM-D
Moderate-Severe depression in both 
partial and total penectomy groups. 
Sig higher Anxiety in total penectomy 
compared to partial (p=0.02)
Gulino et al ., 200710 14 54 Prospective Penile sparing (n=14) IIEF-15
Bigelow & Young
Recovery of similar sexual function 
compared to preop. Satisfactory QoL
Romero et al ., 
20057
18 52 Retrospective Partial Pen (n= 18) IIEF-15 Erectile function, orgasmic function, 
sexual desire, intercourse satisfaction, 
overall sexual satisfaction were 
significantly reduced
Windahl et al ., 
200411
40 64 Retrospective YAG laser ablation (n=40) IIEF-11
LiSat-11
Self made sexual 
function
Self made sexual activity
Sexual function and satisfaction only 
marginally reduced compared to 
preop. 72% with sex life as good as 
they wanted,
Ficarra et al ., 
200018
16 n/a Retrospective Partial Pen (n=14) HADS GHQ Significant impairment of the general 
state of health and higher levels of 
anxiety compared to control
Abbreviations: GHQ: General Health Questionnaire; HAM-A: Hamilton Anxiety Rating Scale, HAM-D: Hamilton Rating Scale for Depression; IOC: Impact of Cancer (Version 2); IIEF-15: International Index of Erectile Function; LiSat-11: Life Satisfaction in 18- to 64-year-old Swedes; SAS: SelfRating Anxiety Scale; SDS: Self-Rating Depression Scale; SF-36: Short Form -36 Health Survey

 

REFERENCES

1. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, Goodman MT, King JB, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer. 2008; 113: 2883-2891.

2. Maddineni SB, Lau MM, SangarVK. Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol. 2009; 9: 8.

3. Ornellas AA. Management of penile cancer. J SurgOncol. 2008; 97: 199-200.

4. Miralles-Guri C, Bruni L, Cubilla AL, Castellsagué X, Bosch FX, de Sanjosé S. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009; 62: 870-878.

5. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005; 116: 606-616.

6. Yu C, Hequn C, Longfei L, Minfeng C, Zhi C, Feng Z, et al. Sexual Function after Partial Penectomy: A Prospectively Study From China. Sci Rep. 2016; 6: 21862.

7. Romero FR, Romero KR, Mattos MA, Garcia CR, Fernandes Rde C, Perez MD. Sexual function after partial penectomy for penile cancer. Urology. 2005; 66: 1292-1295.

8. Novac B, Ciobica A, Dobrin R, Ciobotaru M, Costache C. Psychological/ psychiatric trauma in patients with penile cancer and partial or total penectomy. Arch Biol Sci. 2013; 65: 1293-1298.

9. Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of life for patients treated for penile cancer. J Urol. 2014; 192: 1105-1110.

10. Gulino G, Sasso F, Falabella R, Bassi FB. Distal urethral reconstruction of the glans for penile carcinoma: results of a novel technique at 1-year of follow-up. J Urol. 2007; 178: 941-944.

11. Windahl T, Skeppner E, Andersson SO, Fugl-Meyer KS. Sexual function and satisfaction in men after laser treatment for penile carcinoma. J Urol. 2004; 172: 648-651.

12. Schneider RK. The suicidal patient. In: McKean SC, Ross JJ, Dress- ler DD, Brotman DJ, Ginsberg JS, eds. Principles and Practice of Hospital Medicine. New York: McGraw-Hill; 2002: 1915-1920.

13. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER), 2013. Bethesda, MD: National Cancer Institute; 2013.

14. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: final data for 2003. Natl Vital Stat Rep. 2006; 54: 1-120.

15. Kim SM, Baek JH, Han DH, Lee YS, Yurgelun-Todd DA. Psychosocialenvironmental risk factors for suicide attempts in adolescents with suicidal ideation: findings from a sample of 73,238. Suicide Life Threat Behav. 2015; 45: 477-487.

16. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. J Clin Oncol. 2008; 26: 4731-4738.

17. Ury HK, Wiggins AD. Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio). Am J Epidemiol. 1985; 122: 197-198.

18. Ficarra V, Righetti R, D’Amico A, Pilloni S, Balzarro M, Schiavone D, et al. General state of health and psychological well-being in patients a er surgery for urological malignant neoplasms. Urol Int. 2000; 65: 130-134. 19.Klaassen Z, Jen RP, DiBianco JM, Reinstatler L, Li Q, Madi R, et al. Factors associated with suicide in patients with genitourinary malignancies. Cancer. 2015; 121: 1864-1872.

Received : 12 Dec 2016
Accepted : 27 Jan 2017
Published : 30 Jan 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X